{"title":"[Coronary Artery Spasm during Anesthesia: Discussion of Cases Leading to Circulatory Collapse through 51 Reports of the Published Literature].","authors":"Takako Sasai, Satoshi Nogaml, Koji Kabutan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Perioperative coronary artery spasm (GAS) is one of the serious complications leading to circulatory collapse. Here we retrospectively examined the impact of CAS and discussed its prevention strate- gies.</p><p><strong>Methods: </strong>Reports of intraoperative CAS were iden- tified by using the PubMed and by manually searching the Journal of Japan Society for Clinical Anesthesia (2001-2015). Analyses were performed on 51 patients who developed CAS and had had no history of isch- emic heart disease.</p><p><strong>Results: </strong>Of the 51 analyzed patients, 19 developed circulatory collapse. In these patients, the rate of early administration of a sufficient dose of a coronary vasodi- lator was low, and they tended to have prolonged and/ or recurrent attacks. Among them, two patients may have had a problem due to the dosage and/or admin- istration method for coronary vasodilator, despite early administration. In addition, we found that a combina- tion of general anesthesia and epidural block may have contributed to the collapse. In three cases, it was diffi- cult to identify the predictors of circulatory collapse.</p><p><strong>Conclusions: </strong>Awareness of CAS and vigilant moni- toring are crucial for preventing circulatory collapse. When a transient ST-segment change indicates possi- ble CAS, adequate dosages of a coronary vasodilator should be promptly administered.</p>","PeriodicalId":18254,"journal":{"name":"Masui. The Japanese journal of anesthesiology","volume":"66 2","pages":"211-217"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Masui. The Japanese journal of anesthesiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Perioperative coronary artery spasm (GAS) is one of the serious complications leading to circulatory collapse. Here we retrospectively examined the impact of CAS and discussed its prevention strate- gies.
Methods: Reports of intraoperative CAS were iden- tified by using the PubMed and by manually searching the Journal of Japan Society for Clinical Anesthesia (2001-2015). Analyses were performed on 51 patients who developed CAS and had had no history of isch- emic heart disease.
Results: Of the 51 analyzed patients, 19 developed circulatory collapse. In these patients, the rate of early administration of a sufficient dose of a coronary vasodi- lator was low, and they tended to have prolonged and/ or recurrent attacks. Among them, two patients may have had a problem due to the dosage and/or admin- istration method for coronary vasodilator, despite early administration. In addition, we found that a combina- tion of general anesthesia and epidural block may have contributed to the collapse. In three cases, it was diffi- cult to identify the predictors of circulatory collapse.
Conclusions: Awareness of CAS and vigilant moni- toring are crucial for preventing circulatory collapse. When a transient ST-segment change indicates possi- ble CAS, adequate dosages of a coronary vasodilator should be promptly administered.
背景:围手术期冠状动脉痉挛是导致循环衰竭的严重并发症之一。在这里,我们回顾性地研究了CAS的影响并讨论了其预防策略。方法:通过PubMed检索和人工检索日本临床麻醉学会杂志(Journal of Japan Society for Clinical Anesthesia, 2001-2015)对术中CAS的报告进行检索。对51例无缺血性心脏病史的CAS患者进行了分析。结果:51例患者中,19例发生循环衰竭。在这些患者中,早期给予足够剂量的冠状动脉血管扩张剂的比率很低,并且他们倾向于延长和/或反复发作。其中,2例患者可能由于冠状动脉血管扩张剂的剂量和/或给药方法而出现问题,尽管早期给药。此外,我们发现全身麻醉和硬膜外阻滞的联合可能是导致崩溃的原因。在三个病例中,很难确定循环衰竭的预测因素。结论:对急性心衰的认识和警惕监测是预防循环衰竭的关键。当短暂的st段改变提示可能发生CAS时,应及时给予适当剂量的冠状动脉血管扩张剂。